U.S. drug prices hit by insurer tactic against copay assistance: analysis


A lately followed tactic by U.S. well being plans to restrict the monetary help drugmakers supply at once to customers for prescription drugs is taking a toll on drug prices, consistent with a brand new analysis launched on Tuesday. Real U.S. drug prices, together with reductions and rebates, fell five.6 % within the first quarter of this yr, in comparison to a 1.7 % drop in the similar duration a yr in the past, consistent with Sector & Sovereign analysis analyst Richard Evans.

Source link

Leave a Reply

Your email address will not be published. Required fields are marked *